Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

381

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

May 18, 2006

Study Completion Date

May 18, 2006

Conditions
Myofascial Pain Syndromes
Interventions
BIOLOGICAL

Botulinum toxin type A

Trial Locations (22)

12850

Institute of Rheumatology, Prague

20022

Osrodek Badan Klinicznych, Lublin

24149

Neurologisch-Verhaltensmedizinische Schmerzklinik Kiel, Kiel

27040

Fondazione Salvatore Maugeri, Montescano

30008

Hospital Morales Meseguer, Murcia

35128

Azienda Ospedaliera di Padova, Padua

44789

Neurology Clinic, Klinikum der Ruhr-Universitat Bochum, Bochum

48129

Clinic for Neurology, Westfalische Wilhelmsuniversitat, Münster

60311

Schmerzzentrum Frankfurt, Frankfurt am Main

65191

Aukammallee 33, Wiesbaden

73033

Schmerzzentrum Goppingen, Göppingen

82300

Centrum Kliniczno-Badawcze, Elblag

87100

Nasz Lekarz NZOZ Praktyka Grupowa Lekarzy, Torun

656 91

Pain Treatment Centre, Anesthesiology & Resuscitation, St Ann Teaching Hospital, Brno

775 20

Dept Neurology, Teaching Hospital Olomouc, Olomouc

07747

Klinik fur Anaesthesiologie und Intensivtherapie, Jena

02341

Centrum Medyczne OSTEOMED NZOZ, Warsaw

1649-035

Hospital de Santa Maria, Lisbon

08916

Hospital Univ Germans Trias i Pujol, Badalona

08035

Hospital de Traumatologia de la Vall d'Hebrón, Barcelona

08036

Hospedale Clinic I Provincial de Barcelona, Barcelona

08907

Hospital Universitari de Bellvitge, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Ipsen

INDUSTRY